Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Umamaheshwar Puppala, Koduri S V Srinivas, K Venkateshwara Reddy, Muralidharan Kaliyaperumal, Raju Doddipalla & Bhaskar Rao Jogi. (2020) Isolation and Characterization of Novel Degradation Products of Eliglustat Tartrate Using 2D-NMR and HRMS: Development and Validation of Stability Indicating RP-UPLC Method for Quantification of Assay and Characterized Impurities. Analytical Chemistry Letters 10:1, pages 1-20.
Read now
Read now
Anna Tylki-Szymańska & Agnieszka Jurecka. (2015) Prospective therapies for mucopolysaccharidoses. Expert Opinion on Orphan Drugs 3:11, pages 1241-1253.
Read now
Read now
Agnieszka Jurecka & Anna Tylki-Szymańska. (2015) Enzyme replacement therapy: lessons learned and emerging questions. Expert Opinion on Orphan Drugs 3:3, pages 293-305.
Read now
Read now
Einat B Vitner, Ayelet Vardi, Timothy M Cox & Anthony H Futerman. (2015) Emerging therapeutic targets for Gaucher disease. Expert Opinion on Therapeutic Targets 19:3, pages 321-334.
Read now
Read now
Eline Picavet, David Cassiman & Steven Simoens. (2013) Do ultra-orphan medicinal products warrant ultra-high prices? A review. Orphan Drugs: Research and Reviews 3, pages 23-31.
Read now
Read now
James A Shayman. (2013) Eliglustat tartrate, a prototypic glucosylceramide synthase inhibitor. Expert Review of Endocrinology & Metabolism 8:6, pages 491-504.
Read now
Read now
Articles from other publishers (6)
Majdolen Istaiti, Michal Becker-Cohen, Tama Dinur, Shoshana Revel-Vilk & Ari Zimran. (2022) Real-Life Experience with Oral Eliglustat in Patients with Gaucher Disease Previously Treated with Enzyme Replacement Therapy. Journal of Clinical Medicine 11:21, pages 6265.
Crossref
Crossref
Kris Dammen-Brower, Paige Epler, Stanley Zhu, Zachary J. Bernstein, Paul R. Stabach, Demetrios T. Braddock, Jamie B. Spangler & Kevin J. Yarema. (2022) Strategies for Glycoengineering Therapeutic Proteins. Frontiers in Chemistry 10.
Crossref
Crossref
Yael Pewzner-Jung, Tammar Joseph, Shani Blumenreich, Ayelet Vardi, Natalia Santos Ferreira, Soo Min Cho, Raya Eilam, Michael Tsoory, Inbal E. Biton, Vlad Brumfeld, Rebecca Haffner-Krausz, Ori Brenner, Nir Sharabi, Yoseph Addadi, Tomer-Meir Salame, Ron Rotkopf, Noa Wigoda, Nadav Yayon, Alfred H. Merrill Jr.Raphael Schiffmann & Anthony H. Futerman. (2021) Brain pathology and cerebellar purkinje cell loss in a mouse model of chronic neuronopathic Gaucher disease. Progress in Neurobiology 197, pages 101939.
Crossref
Crossref
Evgeniy Protasov, Larisa Koleva, Elizaveta Bovt, Fazoil I. Ataullakhanov & Elena Sinauridze. (2021) Theoretical Analysis of the Built-in Metabolic Pathway Effect on the Metabolism of Erythrocyte-Bioreactors That Neutralize Ammonium. Metabolites 11:1, pages 36.
Crossref
Crossref
Keiko Nakata, Satoshi Takeda, Atsushi Tanaka, Jimmy Kwang & Jun Komano. (2017) Antiviral activity of acid beta-glucosidase 1 on enterovirus 71, a causative agent of hand, foot and mouth disease. Journal of General Virology 98:4, pages 643-651.
Crossref
Crossref
Azza Dandana, Souhaira Ben Khelifa, Hinda Chahed, Abdelhédi Miled & Salima Ferchichi. (2016) Gaucher Disease: Clinical, Biological and Therapeutic Aspects. Pathobiology 83:1, pages 13-23.
Crossref
Crossref